A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study

被引：0
|
作者：
Patrizia Vici
Giuseppe Colucci
Francesco Giotta
Domenico Sergi
Gianfranco Filippelli
Pasquale Perri
Claudio Botti
Enrico Vizza
Armando Carpino
Laura Pizzuti
Agnese Latorre
Diana Giannarelli
Massimo Lopez
Luigi Di Lauro
机构：
[1] Regina Elena National Cancer Institute,Division of Medical Oncology B
[2] Oncologic Institute,Department of Medical and Experimental Oncology
[3] Division of Medical Oncology,Division of Surgery A
[4] S. Francesco Hospital,Division of Gynecological Oncology
[5] Regina Elena National Cancer Institute,Cardiologic Unit
[6] Regina Elena National Cancer Institute,Biostatistics Unit
[7] Regina Elena National Cancer Institute,undefined
[8] Regina Elena National Cancer Institute,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 30卷
关键词：
Anthracyclines; Lapatinib; Pegylated Liposomal Doxorubicin; Neutropenic Fever; Advanced Breast Cancer Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer:: Results of a prospective randomized phase II study
    Esteban, E
    Fra, J
    Fernández, Y
    Corral, N
    Vieitez, JM
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 241 - 248
  • [22] A phase II study of epirubicin, vinorelbine and cisplatin in advanced breast cancer
    Garrone, O
    Principe, E
    Occelli, M
    Mercuri, M
    Numico, G
    Granetto, C
    Di Costanzo, G
    Rattazzi, PD
    Merlano, M
    ANTI-CANCER DRUGS, 2004, 15 (01) : 23 - 27
  • [23] First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study
    Pectasides, D
    Dimopoulos, MA
    Aravantinos, G
    Kalophonos, HP
    Papacostas, P
    Briasoulis, E
    Cogas, E
    Papadimitriou, C
    Skarlos, D
    Kosmidis, P
    Fountzilas, G
    ANTICANCER RESEARCH, 2001, 21 (05) : 3575 - 3580
  • [24] Navcap (vinorelbine and capecitabine) versus navcap followed by weekly docetaxel as first-line treatment in metastatic breast cancer patients: A randomized multicenter phase II trial
    Ghosn, M.
    Farhat, F. S.
    Kattan, J. G.
    Hanna, C.
    Younes, F.
    Haddad, N.
    Aftimos, P.
    Nasr, F.
    Moukadem, W.
    Chahine, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Pegylated Liposomal Doxorubicin (Caelyx®) and Oral Vinorelbine in First-Line Metastatic Breast Cancer Patients Previously Treated with Anthracyclines
    Livi, L.
    Meattini, I.
    Scotti, V.
    Cardillo, C. De Luca
    Galardi, A.
    Iermano, C.
    Sanchez, L.
    Nori, J.
    Mangoni, M.
    Franzese, C.
    Orzalesi, L.
    Bertocci, S.
    Agresti, B.
    Masoni, T.
    Bianchi, S.
    Cataliotti, L.
    Biti, G.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (03) : 158 - 162
  • [26] Phase II study of pegylated liposomal doxorubicin (Caelyx®) and docetaxel as first-line treatment in metastatic breast cancer
    Alexopoulos, A
    Karamouzis, MV
    Stavrinides, H
    Ardavanis, A
    Kandilis, K
    Stavrakakis, J
    Georganta, C
    Rigatos, G
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 891 - 895
  • [27] A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer
    Subramanyan, S
    Abeloff, MD
    Bond, SE
    Davidson, NE
    Fetting, JH
    Gordon, GB
    Kennedy, MJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (06) : 497 - 502
  • [28] A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer
    Smitha Subramanyan
    Martin D. Abeloff
    Stephen E. Bond
    Nancy E. Davidson
    John H. Fetting
    Gary B. Gordon
    M. John Kennedy
    Cancer Chemotherapy and Pharmacology, 1999, 43 : 497 - 502
  • [29] Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancer
    Ardizzoia, Antonio
    Colombo, Ilaria
    Giordano, Monica
    Aglione, Stefania
    Isa, Luciano
    Scanni, Alberto
    Scognamiglio, Giovanni
    Bertolini, Alessandro
    Villa, Federica
    Gardani, Gianstefano
    TUMORI JOURNAL, 2007, 93 (06): : 544 - 549
  • [30] Activity and safety of vinorelbine combined with doxorubicin or fluorouracil as first-line therapy in advanced breast cancer: A stratified phase II study
    Hochster, HS
    Vogel, CL
    Burman, SL
    White, R
    ONCOLOGIST, 2001, 6 (03): : 269 - 277
12345